Pennant Group, Inc. (PNTG)
Nasdaq · Services-Health Services · Services · CIK 1766400 · fiscal year ends in Dec
Closing price $42.46 on 29 Oct 2026; 52-week range $23.75 to $42.60.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $1.1B
- Revenue growth
- 37.9%
- Net income, last twelve months
- $32.3M
- Earnings per share
- $0.90
- Gross margin
- 18.5%
- Operating margin
- 5.6%
- Net margin
- 2.9%
- Free cash flow
- $34.7M
- Return on equity
- 8.0%
- Market value
- $1.5B
- Price to earnings
- 47.2x
- Cash
- $15.3M
- Debt
- $197.5M
- Debt to equity
- 0.49
- Shares outstanding
- 34.8M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $947.7M | $51.9M | $29.6M | $0.84 | $36.3M | 10-K filed 26 Feb 2026 |
| FY2024 | 31 Dec 2024 | $695.2M | $38.1M | $22.6M | $0.70 | $30.3M | 10-K filed 27 Feb 2025 |
| FY2023 | 31 Dec 2023 | $544.9M | $25.2M | $13.4M | $0.44 | $25.0M | 10-K filed 28 Feb 2024 |
| FY2022 | 31 Dec 2022 | $473.2M | $12.7M | $6.6M | $0.22 | -$5.1M | 10-K filed 23 Feb 2023 |
| FY2021 | 31 Dec 2021 | $439.7M | $4.7M | $2.7M | $0.09 | -$24.5M | 10-K filed 28 Feb 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $298.0M | $9.1M | $0.25 |
| Q1 FY2026 | 31 Mar 2026 | $285.4M | $8.5M | $0.24 |
| Q4 FY2025 | 31 Dec 2025 | $289.3M | $8.6M | $0.24 |
| Q3 FY2025 | 30 Sep 2025 | $229.0M | $6.1M | $0.17 |
| Q2 FY2025 | 30 Jun 2025 | $219.5M | $7.1M | $0.20 |
| Q1 FY2025 | 31 Mar 2025 | $209.8M | $7.8M | $0.22 |
| Q4 FY2024 | 31 Dec 2024 | $188.9M | $5.8M | $0.16 |
| Q3 FY2024 | 30 Sep 2024 | $180.7M | $6.2M | $0.20 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By business, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Home Health and Hospice Services | $731.4M | 77.7% |
| Senior Living Services | $210.1M | 22.3% |
Company events
The newest 8-K filings of 60 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 5 Aug 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 20 May 2026 | 8-K | Shareholder vote | 5.07, 9.01 |
| 6 May 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 25 Feb 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 5 Nov 2025 | 8-K | Material agreement, New debt | 1.01, 2.03, 9.01 |
| 5 Nov 2025 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 2 Oct 2025 | 8-K/A | Investor update | 7.01, 9.01 |
| 2 Oct 2025 | 8-K | Material agreement | 1.01, 9.01 |
| 2 Oct 2025 | 8-K | Deal completed, Investor update | 2.01, 7.01, 9.01 |
| 6 Aug 2025 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 20 May 2025 | 8-K | Shareholder vote | 5.07, 9.01 |
| 6 May 2025 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
Every filing
The newest filings with the SEC of 130 held.
| Filed | Form | Period |
|---|---|---|
| 5 Aug 2026 | 10-Q | 30 Jun 2026 |
| 5 Aug 2026 | 8-K | 5 Aug 2026 |
| 20 May 2026 | 8-K | 20 May 2026 |
| 6 May 2026 | 10-Q | 31 Mar 2026 |
| 6 May 2026 | 8-K | 6 May 2026 |
| 31 Mar 2026 | DEF 14A | 14 May 2026 |
| 26 Feb 2026 | 10-K | 31 Dec 2025 |
| 25 Feb 2026 | 8-K | 25 Feb 2026 |
| 17 Dec 2025 | 8-K/A | 2 Oct 2025 |
| 5 Nov 2025 | 8-K | 5 Nov 2025 |
| 5 Nov 2025 | 10-Q | 30 Sep 2025 |
| 5 Nov 2025 | 8-K | 5 Nov 2025 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 6 Aug 2026 | Cheney Kirk Sterling, EVP, GC and Corp Secy | Sale outside a trading plan | 1,393 | $38.52 | $53.7K | 18,401 | 10 Aug 2026 |
| 6 Aug 2026 | Guerisoli Brent, Chief Executive Officer | Sale outside a trading plan | 4,285 | $38.52 | $165.1K | 99,544 | 10 Aug 2026 |
| 6 Aug 2026 | Steik Jason Paul, Chief Clinical Officer | Sale under a trading plan | 1,394 | $38.52 | $53.7K | 15,106 | 10 Aug 2026 |
| 10 Jul 2026 | Guerisoli Brent, Chief Executive Officer | Sale under a trading plan | 3,159 | $41.56 | $131.3K | 103,829 | 14 Jul 2026 |
| 7 Jul 2026 | Guerisoli Brent, Chief Executive Officer | Sale under a trading plan | 3,165 | $40.51 | $128.2K | 100,740 | 9 Jul 2026 |
| 22 May 2026 | Guerisoli Brent, Chief Executive Officer | Sale under a trading plan | 22 | $34.86 | $767 | 97,679 | 27 May 2026 |
| 22 May 2026 | Guerisoli Brent, Chief Executive Officer | Sale under a trading plan | 2,032 | $35.08 | $71.3K | 95,647 | 27 May 2026 |
| 22 May 2026 | Guerisoli Brent, Chief Executive Officer | Sale under a trading plan | 200 | $35.10 | $7.0K | 95,447 | 27 May 2026 |
| 22 May 2026 | Guerisoli Brent, Chief Executive Officer | Sale under a trading plan | 2,254 | $35.08 | $79.1K | 97,656 | 27 May 2026 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 6 Aug 2026 | Cheney Kirk Sterling, Officer | 1,393 | $53.7K | 6 Aug 2026 |
| 6 Aug 2026 | Steik Jason Paul, Officer | 1,394 | $53.7K | 6 Aug 2026 |
| 6 Aug 2026 | Guerisoli Brent, Officer, Director | 4,285 | $165.1K | 6 Aug 2026 |
| 10 Jul 2026 | Guerisoli Brent, Officer, Director | 3,159 | $131.3K | 10 Jul 2026 |
| 7 Jul 2026 | Guerisoli Brent, Officer, Director | 3,165 | $128.2K | 7 Jul 2026 |
| 22 May 2026 | Guerisoli Brent, Officer, Director | 4,508 | $158.1K | 22 May 2026 |
| 14 May 2026 | Gochnour John J, Officer | 4,639 | $170.7K | 14 May 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 31 Jul 2026 | Vanguard Capital Management | 13G | 5.01% | 1.7M |
| 17 Jul 2026 | Wasatch Advisors LP | 13G | 5.4% | 1.9M |
| 27 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 17 Feb 2026 | 8 Knots Management, LLC | 13G amended | 0.03% | 8.7K |
| 20 Jan 2026 | Van Berkom & Associates Inc. | 13G amended | 9% | 3.1M |
| 14 Nov 2025 | 8 KNOTS MANAGEMENT, LLC | 13G amended | 5.04% | 1.7M |
| 5 Nov 2025 | Van Berkom & Associates Inc. | 13G amended | 0% | 0 |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 1.1M | -2.91% | 3.49 |
| 30 Sep 2026 | 1.2M | +11.62% | 2.32 |
| 15 Sep 2026 | 1.1M | +20.9% | 4.45 |
| 31 Aug 2026 | 876.6K | +13.85% | 3.77 |
| 14 Aug 2026 | 769.9K | +15.39% | 2.41 |
| 31 Jul 2026 | 667.3K | -7.95% | 2.93 |
| 15 Jul 2026 | 724.9K | -7.09% | 2.03 |
| 30 Jun 2026 | 780.2K | +23.65% | 2.17 |
Funds that hold it
From each fund's latest Form 13F.
225 funds held it at 30 Jun 2026: 95 added and 66 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 2,959,141 | $109.3M | +243,076 |
| Van Berkom & Associates Inc. | 2,369,269 | $87.5M | -2,969,599 |
| Wasatch Advisors LP | 1,870,178 | $69.1M | +451,491 |
| Turtle Creek Asset Management Inc. | 1,714,462 | $63.3M | +131,639 |
| Vanguard Capital Management LLC | 1,480,881 | $54.7M | +29,913 |
| Paradigm Capital Management Inc. | 1,402,800 | $51.8M | -6,000 |
| FMR LLC | 1,182,138 | $43.7M | +79,514 |
| First Eagle Investment Management, LLC | 1,141,000 | $42.2M | – |
| Provident Investment Management, Inc. | 939,208 | $34.7M | -43,807 |
| Goldman Sachs Group Inc. | 891,426 | $32.9M | +260,035 |
Peers
Companies in the same industry.
- LifeStance Health Group, Inc. (LFST): revenue $1.6B, market value $5.2B
- Privia Health Group, Inc. (PRVA): revenue $2.4B, market value $2.8B
- GeneDx Holdings Corp. (WGS): revenue $454.4M, market value $2.1B
- U S Physical Therapy Inc. (USPH): revenue $812.2M, market value $1.3B
- InnovAge Holding Corp. (INNV): revenue $989.7M, market value $1.3B
- Omada Health, Inc. (OMDA): revenue $309.8M, market value $1.2B